Biodexa Pharmaceuticals Plc ADRBDRX
Price$0.63

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Dec 2025
Net Income -$6.4MTTM through 31 Dec 2025
Free Cash Flow -$5.6MTTM through 31 Dec 2025

Margins

Current

Returns

-55.9%ROE
-35.1%ROA

Balance Sheet Health

Debt / Equity0.01x
Current Ratio2.03x
Net Debt-$8.5Mnet cash position
Cash & Equivalents$6.4M

Multi-Year Trend

Revenue
'17'18'19'20'21'22'23
FY2023: $381K
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $0.00

Dividend

No dividend

Segment Performance

No segment data available.

Financials converted at 0.7425 from GBP.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.